Header Logo

Connection

BRADY MOFFETT to Adolescent

Back to Details
This is a "connection" page, showing publications BRADY MOFFETT has written about Adolescent.
BRADY MOFFETT
Connection Strength
1.330
Adolescent
  1. Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy. Eur J Clin Pharmacol. 2019 Aug; 75(8):1089-1097.
    View in: PubMed
    Score: 0.046
  2. Population Pharmacokinetic Assessment of Vancomycin Dosing in the Large Pediatric Patient. Antimicrob Agents Chemother. 2019 04; 63(4).
    View in: PubMed
    Score: 0.046
  3. Population Pharmacokinetics of Vancomycin in Pediatric Extracorporeal Membrane Oxygenation. Pediatr Crit Care Med. 2018 10; 19(10):973-980.
    View in: PubMed
    Score: 0.044
  4. Fosphenytoin Population Pharmacokinetics in the Acutely Ill Pediatric Population. Pediatr Crit Care Med. 2018 08; 19(8):748-754.
    View in: PubMed
    Score: 0.044
  5. Phenobarbital population pharmacokinetics across the pediatric age spectrum. Epilepsia. 2018 07; 59(7):1327-1333.
    View in: PubMed
    Score: 0.043
  6. The "Ideal" Body Weight for Pediatric Gentamicin Dosing in the Era of Obesity: A Population Pharmacokinetic Analysis. Ther Drug Monit. 2018 06; 40(3):322-329.
    View in: PubMed
    Score: 0.043
  7. Population Pharmacokinetics of Enoxaparin in Pediatric Patients. Ann Pharmacother. 2018 02; 52(2):140-146.
    View in: PubMed
    Score: 0.041
  8. Readmissions for Heart Failure in Children. J Pediatr. 2016 10; 177:153-158.e3.
    View in: PubMed
    Score: 0.038
  9. Assessment of inpatient admissions and top 25 medications for obese pediatric patients at two academic hospitals. Am J Health Syst Pharm. 2016 Aug 15; 73(16):1243-9.
    View in: PubMed
    Score: 0.038
  10. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate. Pediatr Nephrol. 2016 11; 31(11):2113-7.
    View in: PubMed
    Score: 0.037
  11. Impact of Body Habitus on Phenytoin Levels Following Fosphenytoin Loading Dose in Pediatric Patients. Ther Drug Monit. 2015 Dec; 37(6):772-5.
    View in: PubMed
    Score: 0.036
  12. Adherence to Anticoagulant Therapy in Pediatric Patients Hospitalized With Pulmonary Embolism or Deep Vein Thrombosis: A Retrospective Cohort Study. Clin Appl Thromb Hemost. 2016 Apr; 22(3):260-4.
    View in: PubMed
    Score: 0.036
  13. Serum digoxin concentrations and clinical signs and symptoms of digoxin toxicity in the paediatric population. Cardiol Young. 2016 Mar; 26(3):493-8.
    View in: PubMed
    Score: 0.035
  14. Response to warfarin therapy in obese pediatric patients dosed according to institutional guidelines. J Pediatr Hematol Oncol. 2014 Nov; 36(8):e487-9.
    View in: PubMed
    Score: 0.034
  15. Trends in parenteral direct thrombin inhibitor use in pediatric patients: analysis of a large administrative database. Arch Pathol Lab Med. 2014 Sep; 138(9):1229-32.
    View in: PubMed
    Score: 0.033
  16. Bioequivalence of enalapril oral solution for treatment of pediatric hypertension and enalapril tablets. Clin Pharmacol Drug Dev. 2014 11; 3(6):493-8.
    View in: PubMed
    Score: 0.033
  17. Vancomycin-associated acute kidney injury in pediatric cardiac intensive care patients. Congenit Heart Dis. 2015 Jan-Feb; 10(1):E6-10.
    View in: PubMed
    Score: 0.033
  18. National prescribing trends for heart failure medications in children. Congenit Heart Dis. 2015 Jan-Feb; 10(1):78-85.
    View in: PubMed
    Score: 0.032
  19. Anticoagulation therapy trends in children supported by ventricular assist devices: a multi-institutional study. ASAIO J. 2014 Mar-Apr; 60(2):211-5.
    View in: PubMed
    Score: 0.032
  20. Amiodarone monitoring practices in pediatric hospitals in the United States. Pediatr Cardiol. 2013; 34(8):1762-6.
    View in: PubMed
    Score: 0.030
  21. Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge. Pediatr Blood Cancer. 2013 Sep; 60(9):1503-6.
    View in: PubMed
    Score: 0.030
  22. Analysis of vancomycin therapeutic drug monitoring trends at pediatric hospitals. Pediatr Infect Dis J. 2013 Jan; 32(1):32-5.
    View in: PubMed
    Score: 0.030
  23. Response to intravenous potassium chloride supplementation in pediatric cardiac intensive care patients. Pediatr Cardiol. 2013 Apr; 34(4):887-92.
    View in: PubMed
    Score: 0.029
  24. Risk factors for postoperative acute kidney injury in pediatric cardiac surgery patients receiving angiotensin-converting enzyme inhibitors. Pediatr Crit Care Med. 2011 Sep; 12(5):555-9.
    View in: PubMed
    Score: 0.027
  25. Heparin dosing in obese pediatric patients in the cardiac catheterization laboratory. Ann Pharmacother. 2011 Jul; 45(7-8):876-80.
    View in: PubMed
    Score: 0.027
  26. Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin J Am Soc Nephrol. 2011 Apr; 6(4):856-63.
    View in: PubMed
    Score: 0.026
  27. Gentamicin dosing for pediatric patients with congenital heart disease. Pediatr Cardiol. 2010 Aug; 31(6):761-5.
    View in: PubMed
    Score: 0.025
  28. Sodium-nitroprusside-induced cyanide toxicity in pediatric patients. Expert Opin Drug Saf. 2009 Sep; 8(5):599-602.
    View in: PubMed
    Score: 0.023
  29. Evaluation of sodium nitroprusside toxicity in pediatric cardiac surgical patients. Ann Pharmacother. 2008 Nov; 42(11):1600-4.
    View in: PubMed
    Score: 0.022
  30. Renal effects of fenoldopam in critically ill pediatric patients: A retrospective review. Pediatr Crit Care Med. 2008 Jul; 9(4):403-6.
    View in: PubMed
    Score: 0.022
  31. Medication dosing and renal insufficiency in a pediatric cardiac intensive care unit: impact of pharmacist consultation. Pediatr Cardiol. 2008 Jul; 29(4):744-8.
    View in: PubMed
    Score: 0.021
  32. Use of fenoldopam to increase urine output in a patient with renal insufficiency secondary to septic shock: A case report. Pediatr Crit Care Med. 2006 Nov; 7(6):600-2.
    View in: PubMed
    Score: 0.019
  33. Oral anticoagulation in a pediatric hospital: impact of a quality improvement initiative on warfarin management strategies. Qual Saf Health Care. 2006 Aug; 15(4):240-3.
    View in: PubMed
    Score: 0.019
  34. Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients. Crit Care Explor. 2024 Oct 01; 6(10):e1159.
    View in: PubMed
    Score: 0.017
  35. Ciprofloxacin-induced renal insufficiency in cystic fibrosis. J Cyst Fibros. 2003 Sep; 2(3):152-4.
    View in: PubMed
    Score: 0.015
  36. Understanding the Role of Pharmacometrics-Based Clinical Decision Support Systems in Pediatric Patient Management: A Case Study Using Lyv Software. J Clin Pharmacol. 2021 06; 61 Suppl 1:S125-S132.
    View in: PubMed
    Score: 0.013
  37. Hospital outcomes for pediatric heart transplant recipients undergoing tracheostomy: A multi-institutional analysis. Pediatr Transplant. 2021 May; 25(3):e13904.
    View in: PubMed
    Score: 0.013
  38. Extracorporeal Membrane Oxygenation Mortality in High-Risk Populations: An Analysis of the Pediatric Health Information System Database. ASAIO J. 2020 03; 66(3):327-331.
    View in: PubMed
    Score: 0.012
  39. Characteristics and outcomes of children with congenital heart disease needing diaphragm plication. Cardiol Young. 2020 Jan; 30(1):62-65.
    View in: PubMed
    Score: 0.012
  40. Characteristics and Outcomes of Pediatric Patients Supported With Ventricular Assist Device-A Multi-Institutional Analysis. Pediatr Crit Care Med. 2019 08; 20(8):744-752.
    View in: PubMed
    Score: 0.012
  41. Thoracic Aortic, Aortic Valve, and Mitral Valve Surgery in Pediatric and Young Adult Patients With Marfan Syndrome: Characteristics and Outcomes. Semin Thorac Cardiovasc Surg. 2019; 31(4):818-825.
    View in: PubMed
    Score: 0.012
  42. Efficacy of liposomal bupivacaine in pediatric patients undergoing spine surgery. Paediatr Anaesth. 2018 11; 28(11):982-986.
    View in: PubMed
    Score: 0.011
  43. Myocardial Stress Perfusion MRI: Experience in Pediatric and Young-Adult Patients Following Arterial Switch Operation Utilizing Regadenoson. Pediatr Cardiol. 2018 Aug; 39(6):1249-1257.
    View in: PubMed
    Score: 0.011
  44. Myocardial stress perfusion magnetic resonance: initial experience in a pediatric and young adult population using regadenoson. Pediatr Radiol. 2017 Mar; 47(3):280-289.
    View in: PubMed
    Score: 0.010
  45. Evaluating the Safety of Intraoperative Antiarrhythmics in Pediatric Cardiac Surgery Patients. Pediatr Cardiol. 2015 Oct; 36(7):1465-9.
    View in: PubMed
    Score: 0.009
  46. Agreement among measurements and estimations of glomerular filtration in children with cancer. Pediatr Blood Cancer. 2015 Jan; 62(1):80-4.
    View in: PubMed
    Score: 0.008
  47. Hypotension as the etiology for angiotensin-converting enzyme (ACE) inhibitor-associated acute kidney injury in pediatric patients. Pediatr Cardiol. 2014 Jun; 35(5):767-70.
    View in: PubMed
    Score: 0.008
  48. Race contributes to beta-blocker efficacy in pediatric patients with arrhythmias. Pediatr Cardiol. 2014 Apr; 35(4):641-4.
    View in: PubMed
    Score: 0.008
  49. Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database. J Thorac Cardiovasc Surg. 2014 Feb; 147(2):678-86.e1; discussion 685-6.
    View in: PubMed
    Score: 0.008
  50. Prescribing errors in adult congenital heart disease patients admitted to a pediatric cardiovascular intensive care unit. Congenit Heart Dis. 2014 Mar-Apr; 9(2):126-30.
    View in: PubMed
    Score: 0.008
  51. Infectious complications and outcomes in children supported with left ventricular assist devices. J Heart Lung Transplant. 2013 May; 32(5):518-24.
    View in: PubMed
    Score: 0.007
  52. Evaluation of weight-based dosing of unfractionated heparin in obese children. J Pediatr. 2013 Jul; 163(1):150-3.
    View in: PubMed
    Score: 0.007
  53. Comparison of anti-Xa levels in obese and non-obese pediatric patients receiving treatment doses of enoxaparin. J Pediatr. 2013 Feb; 162(2):293-6.
    View in: PubMed
    Score: 0.007
  54. Warfarin anticoagulation after congenital heart surgery at a large children's hospital. Pediatr Cardiol. 2012 Dec; 33(8):1377-82.
    View in: PubMed
    Score: 0.007
  55. Altered gentamicin serum concentrations in obese pediatric patients. Pediatr Infect Dis J. 2011 Apr; 30(4):347-9.
    View in: PubMed
    Score: 0.007
  56. Impact of dexmedetomidine on early extubation in pediatric cardiac surgical patients. Intensive Care Med. 2011 Apr; 37(4):686-90.
    View in: PubMed
    Score: 0.006
  57. Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients. J Am Coll Cardiol. 2010 Aug 10; 56(7):582-92.
    View in: PubMed
    Score: 0.006
  58. Once-daily gentamicin dosing in pediatric patients without cystic fibrosis. Pharmacotherapy. 2010 Mar; 30(3):248-53.
    View in: PubMed
    Score: 0.006
  59. Safety and efficacy of nesiritide in pediatric heart failure. J Card Fail. 2007 Sep; 13(7):541-8.
    View in: PubMed
    Score: 0.005
  60. An alternative treatment strategy for pump thrombus in the DeBakey VAD Child: use of clopidogrel as a thrombolytic agent. J Heart Lung Transplant. 2006 Jul; 25(7):857-61.
    View in: PubMed
    Score: 0.005
  61. A prospective evaluation of nesiritide in the treatment of pediatric heart failure. Pediatr Cardiol. 2006 Jul-Aug; 27(4):402-7.
    View in: PubMed
    Score: 0.005
  62. Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart failure. J Card Fail. 2006 Mar; 12(2):139-43.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.